Forte Biosciences (FBRX) Balance Sheet: Assets & Liabilities

Forte Biosciences (FBRX) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), Forte Biosciences reported total assets of $82.78M and total liabilities of $21.79M. Shareholders' equity was $60.99M, up 16.2% from $52.48M a year earlier. Total debt stood at $0.00 against $76.96M in cash and short-term investments, a net cash position of $76.96M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Forte Biosciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Forte Biosciences, Inc. (FBRX) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	76.96	76.96	22.24	22.24	11.96	41.10	42.04	58.77	6.94	40.81	35.93
Short-Term Investments	0.00	-	36.12	36.12	25.16	0.00	0.00	0.00	0.00	55.27	52.79
Cash & Short-Term Investments	76.96	76.96	58.37	58.37	37.13	41.10	42.04	58.77	6.94	96.09	88.73
Accounts Receivable	0.82	0.82	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.82	0.42	2.98	2.98	1.20	0.41	0.48	1.13	0.57	1.66	1.90
Total Current Assets	80.59	80.59	61.35	61.35	38.33	41.51	42.52	59.90	7.51	97.75	90.63
Non-Current Assets
Property, Plant & Equipment (Net)	0.13	0.13	0.08	0.08	0.11	0.00	0.00	0.10	0.15	3.97	1.22
Other Non-Current Assets	2.06	0.03	0.14	0.14	0.54	0.49	0.79	1.24	0.00	1.36	0.23
Total Non-Current Assets	2.19	2.19	0.22	0.22	0.65	0.49	0.79	1.34	0.15	5.33	1.44
Total Assets	82.78	82.78	61.56	61.56	38.98	42.00	43.31	61.24	7.66	103.08	92.07
Current Liabilities
Accounts Payable	9.99	9.99	4.88	4.88	1.42	1.15	0.95	1.24	1.57	0.08	1.95
Short-Term Debt	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	4.71
Accrued Liabilities	-	8.51	-	4.20	1.30	2.03	0.81	1.02	-	-	-
Deferred Revenue	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00	0.04	0.06
Other Current Liabilities	9.73	-	4.20	-	2.24	2.03	0.81	1.02	0.34	16.42	10.61
Total Current Liabilities	20.75	20.75	9.08	9.08	3.67	3.18	1.76	2.26	1.91	16.53	17.33
Non-Current Liabilities
Long-Term Debt	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00	26.20	3.63
Deferred Tax Liabilities	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	-0.04
Other Non-Current Liabilities	1.04	-	0.00	-	0.00	0.00	0.00	0.00	0.00	2.20	0.00
Total Non-Current Liabilities	1.04	1.04	0.00	-	0.00	0.00	0.00	0.00	0.00	28.40	3.66
Total Liabilities	21.79	21.79	9.08	9.08	3.67	3.18	1.76	2.26	1.91	44.94	20.99
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.04	0.02	0.02	0.01	0.00	0.02	0.02
Retained Earnings	-223.37	-223.37	-154.00	-154.00	-118.52	-87.04	-73.17	-51.46	-4.97	-215.88	-166.93
Accumulated Other Comprehensive Income	0.00	0.00	0.01	0.01	0.00	0.00	-43.31	-61.24	0.00	-0.02	-0.03
Additional Paid-in Capital	284.35	284.35	206.46	206.46	153.79	125.84	114.70	110.42	0.20	274.03	145.95
Shares Outstanding	-	12.95	-	6.39	1.45	0.84	0.59	-	-	-	-
Total Stockholders' Equity	60.99	60.99	52.48	52.48	35.31	38.82	41.55	58.98	5.75	58.15	71.08
Total Liabilities & Equity	82.78	82.78	61.56	61.56	38.98	42.00	43.31	61.24	7.66	103.08	92.07

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Forte Biosciences Balance Sheet

How much debt does Forte Biosciences have?

Forte Biosciences had total debt of $0.00 as of Mar 31, 2026, against $76.96M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Forte Biosciences's total assets?

Forte Biosciences reported total assets of $82.78M as of Mar 31, 2026, up 34.5% from $61.56M a year earlier. Total liabilities were $21.79M.

What is Forte Biosciences's shareholders' equity?

Forte Biosciences's shareholders' equity was $60.99M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition